Hip Muscle Strengthening and Calf Myofascial Release in Females With Chronic Plantar Fasciitis

November 17, 2026 updated by: Fizza Masood, University of Management and Technology Lahore

Effects of Hip Muscle Strengthening With and Without Myofascial Release of Calf Muscle on Pain and Disability in Females With Chronic Plantar Fasciitis.

This study aims to compare the effects of hip muscle strengthening with and without myofascial release of the calf muscle on pain and disability in females with chronic plantar fasciitis.

Chronic plantar fasciitis is a common cause of heel pain and may lead to limitations in walking, daily activities, and functional performance. Factors such as calf muscle tightness, restricted ankle dorsiflexion, altered lower-limb biomechanics, and proximal hip muscle weakness may contribute to persistent symptoms. Although strengthening exercises and myofascial release have shown beneficial effects, limited evidence is available regarding the combined effect of hip strengthening and calf myofascial release in females with chronic plantar fasciitis.

The study will be conducted as a randomized clinical trial with a total sample of 34 females, aged 25-45 years, who meet the specified criteria for chronic plantar fasciitis. Participants will be randomly allocated into two groups. Group A will receive hip muscle strengthening exercises, while Group B will receive the same strengthening program combined with myofascial release of the calf muscles. Both groups will receive treatment three times per week for six weeks, for a total of 18 sessions.

The primary outcome measures will include the Numeric Pain Rating Scale (NPRS), Foot Function Index (FFI), and Morning First-Step Pain Visual Analogue Scale (VAS). Assessments will be performed at baseline and after completion of the six-week intervention.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • UMT
        • Contact:
        • Contact:
          • Rabia Jawa CoD Physical Therapy and Rehabilitation, MPhil PT
          • Phone Number: +923434570838
          • Email: rabia.jawa@umt.edu.pk
        • Sub-Investigator:
          • Sadia Riaz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Participants fulfilling the diagnostic criteria for plantar fasciitis.
  • Age between 25-45 years.
  • NPRS score between >3-6.
  • History of chronic plantar heel pain for at least 3 consecutive months.
  • Positive Windlass Test.
  • Morning first-step pain intensity >5 cm on a 10-cm Visual Analog Scale (VAS).

Exclusion Criteria:

  • Recent history of foot, ankle, or lower limb surgery.
  • Corticosteroid injection for plantar fasciitis within the previous three months.
  • Diagnosed neurological disorders affecting lower limb function.
  • Pregnancy.
  • Heel pain due to any other systemic inflammatory condition such as rheumatoid arthritis, gout, hyperuricemia (uric acid disorders), or other causes of heel pain.
  • Foot or ankle fracture within the previous six months.
  • Participation in any structured physiotherapy program for plantar fasciitis during the previous month.
  • Presence of tarsal tunnel syndrome, Achilles tendon rupture, or other significant foot pathologies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1: Hip muscles Strengthening Exercises

Participants will receive hip abductor strengthening exercises three sessions per week for six weeks to improve pain and functional outcomes associated with chronic plantar fasciitis.

hip abductor strengthening exercises three sessions per week for six weeks

Active Comparator: Arm 2: Hip muscles Strengthening Exercises Combined with Calf Myofascial Release

Participants will receive hip muscles strengthening exercises combined with myofascial release of the calf muscles three sessions per week for six weeks to evaluate the additional effects of calf myofascial release on pain and functional outcomes associated with chronic plantar fasciitis.

hip muscles strengthening exercises combined with myofascial release of the calf muscles three sessions per week for six weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale (NPRS)
Time Frame: Baseline and after 6 weeks

The Numeric Pain Rating Scale (NPRS) will be used to assess the intensity of pain associated with chronic plantar fasciitis. It is an 11-point numerical scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate greater pain intensity.

Baseline and after 6 weeks
Foot Function Index (FFI)
Time Frame: Baseline and after 6 weeks

The Foot Function Index (FFI) will be used to assess foot-related pain, disability, and activity limitation in females with chronic plantar fasciitis. The questionnaire evaluates the impact of foot symptoms on functional activities. Higher scores indicate greater pain and functional limitations.

Baseline and after 6 weeks
Morning First-Step Pain Visual Analog Scale (VAS)
Time Frame: Baseline and after 6 weeks

The Visual Analog Scale (VAS) will be used to assess pain experienced during the first steps taken in the morning after a period of rest. Participants will indicate their pain intensity on a 10-cm visual analog line, with one end representing no pain and the other representing the worst imaginable pain. Higher scores indicate greater morning first-step pain.

Baseline and after 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 27, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

October 26, 2026

First Submitted That Met QC Criteria

October 26, 2026

First Posted (Actual)

November 2, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 17, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • RE-165-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The results data collected , de-identified individual participant data will be shared.

IPD Sharing Time Frame

6 months after the publication of the manuscript.

IPD Sharing Access Criteria

The data can be requested from the corresponding author.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.